期刊文献+

含铋复合材料对幽门螺杆菌的多联治疗的研究 被引量:2

Research on the application of inorganic bismuth nanocomposites in multiple-inhibition against H. pylori
下载PDF
导出
摘要 将以具有链状高分子结构的柠檬酸铋为模板和前体合成出本身具有抑菌活性的含铋纳米材料,并以此为载体,通过吸附、填充、化学结合等方法与药物小分子或抗生素形成复合材料.研究含铋纳米材料和小分子复合过程的相互作用.评价含铋纳米材料在复合前后对幽门螺杆菌生长的抑制活性的变化.初步研究在模拟生理条件下,纳米材料分解和释放药物的过程,为研究开发新的治疗消化性溃疡疾病的药物提供新的思路. Different bismuth nanomaterials will be synthesized and characterized using bismuth citrate as a template and bismuth precursor, which has linear polymeric structure. Based on this, nanoeomposite materials with antibiotics or small molecules will be designed through adsorption, filling and chemical bonding. The interactions between bismuth nanomaterials and small moleeules will be discussed. The inhibitory activities against H. pylori of bismuth nanomaterials and nanocomposites will be evaluated. Also we will focus on the primary studies on the process of the decomposition of nanocomposites and drug release under a simulated physiological conditions. It can provide a new idea for the research and development of new drugs in the treatment of peptic ulcer disease.
出处 《武汉工程大学学报》 CAS 2009年第1期5-9,共5页 Journal of Wuhan Institute of Technology
基金 国家自然科学基金项目(20801043) 武汉市科技局青年科技晨光计划(200850731376)
关键词 无机复合材料 幽门螺杆菌 多联治疗 bismuth inorganic nanoeomposites H. pylori mutiple-treatment
  • 相关文献

参考文献3

二级参考文献145

  • 1贾如宝.绿色金属──铋(Bi)[J].金属世界,1993(5):22-22. 被引量:6
  • 2蔡中起,曹更福.幽门螺杆菌感染治疗现状[J].国外医学(内科学分册),1995,22(5):209-212. 被引量:25
  • 3[1]Sun H, Sadler PJ. Bismuth antiulcer complexes. Top Biol Inorg Chem, 1999;2:159~185.
  • 4[2]Slikkerveer A, de Wolff FA. Pharmacokinetics and toxicity of bismuth compounds. Med Toxicol Adverse Drug Exp, 1989;4: 303-323.
  • 5[3]Menge H, Gregor M, Brosius B, et al. Pharmacology of bismuth.Eur J Gastroenterol Hepatol 1994, 4(S2): 41~47.
  • 6[4]J.W. Clitherow, United Kingdom Patent GB2220937A, 1990.
  • 7[5]McColm AA, McLaren A, Klinkert G, et al. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrateranitidine admixture. Aliment Pharmacol Therap, 1996; 10:241~250.
  • 8[6]Sadler PJ, Sun H. Ranitidine bismuth citrate. J Chem Soc Dalton Trans, 1995;1395~1401.
  • 9[7]Warren JR, Marshall B, Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet, 1983; i: 1273~1275.
  • 10[8]Blaser MJ Hypotheses on the pathogenesis and natural history of Helicobacterpylori-induced inflammation. Gastroenterology, 1992;102:720~727.

共引文献36

同被引文献5

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部